Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberculosis in East Africa: second report. A co-operative study in East African and British Medical Research Councils.
D000284:Administration, Oral; D000328:Adult; D000636:Aminosalicylic Acids / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007630:Kenya; D008297:Male; D011718:Pyrazinamide / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D013307:Streptomycin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013636:Tanzania; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014454:Uganda
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D013307:Streptomycin